Russia Approves COVID-19 Vaccine Before Trials Completed
TUESDAY, Aug. 11, 2020 -- Before completing clinical trials to ensure the vaccine is safe and effective, the Russian government has gone ahead and approved a vaccine against the new coronavirus, The New York Times reported Tuesday.
Russian President Vladimir Putin's announcement comes despite a lack of published data on any testing for the vaccine. "It works effectively enough, forms a stable immunity and I repeat, it has gone through all necessary tests," Putin told a Cabinet meeting on Tuesday. He also said one of his daughters has been given the vaccine, The Times said.
Last week the World Health Organization urged Russia not to bypass the usual methods of testing to ensure safety and effectiveness. The Russian vaccine was rushed through monkey and early human trials and was most likely successful. But it has not been widely tested in large phase 3 trials. Mikhail Murashko, Russia's minister of health, has said mass vaccination will start in October, beginning with teachers and medical workers.
The Russia approval comes far ahead of when Western countries are expected to have a working vaccine, which is not expected before the end of the year. The United States, Canada, and Britain have accused Russian hackers of trying to steal vaccine research, spurring doubt that Russia has achieved any medical breakthrough on its own.
The Russians have said say their vaccine is based on an Ebola vaccine they developed years ago, The Times reported. The Russian vaccine uses two strains of adenovirus. Similar vaccines are being tested in other countries. It is the approach being used by Oxford University and drug maker AstraZeneca.
© 2020 HealthDay. All rights reserved.
Posted: August 2020
Further Support and Information on COVID-19
Read this next
WEDNESDAY, Sept. 23, 2020 -- For U.S. veterans with COVID-19, mortality is mainly associated with older age, male sex, and comorbidity, according to a study published online Sept....
WEDNESDAY, Sept. 23, 2020 -- For patients with COVID-19, elevated red blood cell distribution width (RDW) is associated with increased mortality risk, according to a study...
WEDNESDAY, Sept. 23, 2020 -- Most people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) do not remain asymptomatic, and the secondary attack rate is...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.